Publications by authors named "Katharine Harding"

Claim this Profile
R
Real-world persistence of multiple sclerosis disease-modifying therapies.
Emma C Tallantyre, Ruth Dobson, Joseph L J Froud, Frederika A St John, Valerie M Anderson, Katharine E Harding

Eur J Neurol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling Disease Progression of Multiple Sclerosis in a South Wales Cohort.
Emeka C Uzochukwu, Katharine E Harding, James Hrastelj, Karim L Kreft, Peter Holmans

Neuroepidemiology· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prodromal multiple sclerosis: considerations and future utility.
Katharine E Harding, Karim L Kreft, Yoav Ben-Shlomo, Neil P Robertson

J Neurol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Multiple Sclerosis Severity Genotype in Predicting Disease Course: A Real-World Cohort.
Karim L Kreft, Emeka Uzochukwu, Sam Loveless, Mark Willis, Ray Wynford-Thomas, Katharine E Harding

Ann Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world annualized relapse rates from contemporary multiple sclerosis clinics in the UK: a retrospective multicentre cohort study.
Athanasios Papathanasiou, Aimee Hibbert, Emma Tallantyre, Katharine Harding, Adithya Panneer Selvam

Neurol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination.
Safiya A Zaloum, Callum H Wood, Pooja Tank, Mae Upcott, Nicola Vickaryous, Katharine E Harding

Mult Scler· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary study of multiple sclerosis disability in South East Wales.
Katharine Elizabeth Harding, Gillian Ingram, Emma Clare Tallantyre, Fady Joseph, Mark Wardle

J Neurol Neurosurg Psychiatry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Life expectancy in multiple sclerosis by EDSS score.
Lucas Walz, Jordan C Brooks, Robert M Shavelle, Neil Robertson, Katharine E Harding

Mult Scler Relat Disord· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring seizure management in hospitals, unmet need, and the impact of the COVID-19 pandemic on seizure presentations to hospital.
Bethan Ellis, Ellie Chilcott, Keri John, Julie Parry, Louise Capeling, Katharine Harding

Seizure· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis.
Emma C Tallantyre, Martin J Scurr, Nicola Vickaryous, Aidan Richards, Valerie Anderson, Katharine E Harding

Mult Scler Relat Disord· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Vaccine Response in People with Multiple Sclerosis.
Emma C Tallantyre, Nicola Vickaryous, Valerie Anderson, Aliye Nazli Asardag, David Baker, Katharine E Harding

Ann Neurol· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-motor phenotypic subgroups in adult-onset idiopathic, isolated, focal cervical dystonia.
Megan E Wadon, Grace A Bailey, Zehra Yilmaz, Emily Hubbard, Meshari AlSaeed, Katharine E Harding

Brain Behav· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum neurofilament-light concentration and real-world outcome in MS.
Valerie Anderson, Emily Bentley, Sam Loveless, Lucia Bianchi, Katharine E Harding

J Neurol Sci· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin-oligodendrocyte antibody disease.
Giordani Rodrigues Dos Passos, Liene Elsone, Sebastian Luppe, Joanna Kitley, Silvia Messina, Katharine Harding

J Neurol Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort.
Emma C Tallantyre, Daniel Castle, Paul Karamura, Thomas A W Brice, Fady Joseph, Katharine E Harding

Mult Scler Relat Disord· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple cause of death analysis in multiple sclerosis: A population-based study.
Katharine Harding, Feng Zhu, Mohammed Alotaibi, Thomas Duggan, Helen Tremlett

Neurology· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cautious Interpretation of Observational Data-Reply.
Katharine E Harding, Emma C Tallantyre, Neil P Robertson

JAMA Neurol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How common is truly benign MS in a UK population?
Emma Clare Tallantyre, Paula C Major, Michael J Atherton, W Adam Davies, Fady Joseph, Katharine Elizabeth Harding

J Neurol Neurosurg Psychiatry· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis.
Katharine Harding, Owain Williams, Mark Willis, James Hrastelj, Anthony Rimmer

JAMA Neurol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic status and disability progression in multiple sclerosis: A multinational study.
Katharine E Harding, Mark Wardle, Robert Carruthers, Neil Robertson, Feng Zhu

Neurology· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New rare genetic variants in multiple sclerosis.
Katharine E Harding, Neil P Robertson

J Neurol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
J William L Brown, Alasdair Coles, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Katharine Harding

JAMA· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the 2017 revisions to McDonald criteria on the diagnosis of multiple sclerosis.
Rebecca Beesley, Valerie Anderson, Katharine E Harding, Fady Joseph, Valentina Tomassini

Mult Scler· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A contemporary study of mortality in the multiple sclerosis population of south east Wales.
Katharine Harding, Valerie Anderson, Owain Williams, Mark Willis, Sara Butterworth

Mult Scler Relat Disord· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis.
Sam Loveless, James W Neal, Owain W Howell, Katharine E Harding, Patrick Sarkies

Brain Pathol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis